Immense ingenuity and unprecedented levels of funding are available for drug discovery, yet pharmaceutical research and development is failing to produce the medicines society requires. New organisational models of drug discovery are clearly needed, and members of the Oxford Martin Programme on Affordable Medicines will contend that open science approaches represent a promising path forward.
"Transforming drug discovery – the pathway to innovation"
02 February 2018
with Professor Chas Bountra
Pro Vice-Chancellor (Innovation)
Professor Chas Bountra is Professor of Translational Medicine and Pro Vice-Chancellor for Innovation at the University of Oxford. He is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the De...